Summitry LLC Merck & Co., Inc. Transaction History

Summitry LLC

$2.18 Billion
Q3 2025

A detailed history of Summitry LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Summitry LLC holds 4,589 shares of MRK stock, worth $426,134. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,589

Previous 3,265 40.55%

Holding current value

$426,134

Previous $258,000 49.22%

% of portfolio

0.02%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$77.6 - $87.37 $102,742 - $115,677	1,324 Added 40.55%	4,589 $385,000
Q2 2025 Aug 08, 2025	SELL	$73.47 - $87.12 $16,898 - $20,037	-230 Reduced 6.58%	3,265 $258,000
Q1 2025 May 13, 2025	BUY	$83.01 - $101.02 $24,986 - $30,407	301 Added 9.42%	3,495 $313,000
Q4 2024 Feb 11, 2025	SELL	$96.31 - $114.76 $53,355 - $63,577	-554 Reduced 14.78%	3,194 $317,000
Q3 2024 Nov 07, 2024	BUY	$111.15 - $128.97 $102,258 - $118,652	920 Added 32.53%	3,748 $425,000

Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $46,425 - $49,860	-375 Reduced 11.71%	2,828 $350,000
Q1 2024 May 06, 2024	BUY	$113.24 - $131.95 $25,365 - $29,556	224 Added 7.52%	3,203 $422,000
Q4 2023 Feb 07, 2024	BUY	$100.18 - $109.02 $12,622 - $13,736	126 Added 4.42%	2,979 $324,000
Q3 2023 Nov 03, 2023	SELL	$102.95 - $114.33 $10,295 - $11,433	-100 Reduced 3.39%	2,853 $293,000
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $10,861 - $11,838	-100 Reduced 3.28%	2,953 $340,000
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $25,014 - $27,910	-243 Reduced 7.37%	3,053 $324,000
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $9,093 - $11,659	-104 Reduced 3.06%	3,296 $365,000
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $287,402 - $322,864	3,400 New	3,400 $293,000

Others Institutions Holding MRK

# of Institutions

3,875

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summitry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summitry LLC with notifications on news.

Account